SIRS-Lab Licenses DxS' PCR for Sepsis Test | GenomeWeb
NEW YORK (GenomeWeb News) – German molecular diagnostics firm SIRS-Lab said today that it will use a PCR technology platform from DxS in a sepsis pathogen-detection test in the European Union under a new licensing agreement.
 
SIRS-Lab will use the DxS Scorpions Technology with its Signature sepsis prediction and monitoring test, which it plans to make widely available in the EU in 2009. The companies also have agreed to include an option in the license that would allow SIRS-Lab to use the DxS PCR technology worldwide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.